SOPHiA GENETICS (SOPH) insider Zhenyu Xu plans 10,000-share stock sale

Rhea-AI Filing Summary

SOPHiA GENETICS insider Zhenyu Xu, through Morgan Stanley Smith Barney LLC Executive Financial Services, filed a notice to sell up to 10,000 shares of common stock on NASDAQ. The filing lists an estimated aggregate value of $56,900.00 for the shares as of August 4, 2026.

The shares are identified as Founders Shares originally acquired on June 20, 2012. The notice also references recent Rule 10b5-1 plan sales, including 4,000 shares for $22,819.20 on July 13, 2026 and 7,393 shares for $38,241.77 on July 6, 2026.

Key Figures

Shares proposed for sale: 10,000 shares Estimated aggregate value: $56,900.00 Original acquisition date: 06/20/2012 +3 more

6 metrics

Shares proposed for sale 10,000 shares Common stock covered by the notice to sell

Estimated aggregate value $56,900.00 Value of 10,000 shares as of August 4, 2026

Original acquisition date 06/20/2012 Founders Shares acquisition date

10b5-1 sale 1 4,000 shares for $22,819.20 Sale dated 07/13/2026

10b5-1 sale 2 7,393 shares for $38,241.77 Sale dated 07/06/2026

10b5-1 sale 3 4,000 shares for $20,056.40 Sale dated 06/15/2026

Key Terms

10b5-1, Founders Shares, Executive Financial Services

3 terms

10b5-1 regulatory

"10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Founders Shares financial

"Common | 06/20/2012 | Founders Shares | Issuer"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/04/2026 - 04:37 PM Accepted by SEC EDGAR 08/04/2026 - 04:37 PM Learn about SEC filing dates

FAQ

What does SOPH's recent Form 144 filing disclose?

The filing shows Zhenyu Xu, via Morgan Stanley Smith Barney LLC Executive Financial Services, plans to sell up to 10,000 SOPH common shares on NASDAQ, with an estimated aggregate value of $56,900.00 as of August 4, 2026.

How many SOPH shares are proposed to be sold in this notice?

The notice covers a proposed sale of 10,000 SOPH common shares. These shares are described as Founders Shares originally acquired on June 20, 2012, and are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services.

What prior SOPH share sales by Zhenyu Xu are noted in the Form 144?

The filing lists several recent Rule 10b5-1 plan sales by Zhenyu Xu, including 4,000 shares for $22,819.20 on July 13, 2026 and 7,393 shares for $38,241.77 on July 6, 2026, among other transactions in May and June 2026.

What is the estimated value of the SOPH shares covered by this planned sale?

The 10,000 SOPH common shares covered by the notice have an estimated aggregate value of $56,900.00. This value is tied to the planned sale as of August 4, 2026 on the NASDAQ market.

How are the SOPH shares held for Zhenyu Xu being sold?

The shares are held and to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing indicates sales under a Rule 10b5-1 trading plan, with multiple dated transactions already executed in 2026.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	56900.00	85127825	08/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/20/2012	Founders Shares	Issuer			10000	06/20/2012	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle V8 00000	Common	07/13/2026	4000	22819.20
10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle V8 00000	Common	07/06/2026	7393	38241.77
10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle V8 00000	Common	06/15/2026	4000	20056.40
10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle V8 00000	Common	05/19/2026	608	2797.71
10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle V8 00000	Common	05/13/2026	4000	18168.40

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)